Lincomycin, clindamycin and their applications
Identifieur interne : 001F81 ( Main/Exploration ); précédent : 001F80; suivant : 001F82Lincomycin, clindamycin and their applications
Auteurs : J. Spížek [République tchèque] ; T. Ezanka [République tchèque]Source :
- Applied Microbiology and Biotechnology [ 0175-7598 ] ; 2004-05-01.
Abstract
Abstract: Lincomycin and clindamycin are lincosamide antibiotics used in clinical practice. Both antibiotics are bacteriostatic and inhibit protein synthesis in sensitive bacteria. They may even be bactericidal at the higher concentrations that can be reached in vivo . Clindamycin is usually more active than lincomycin in the treatment of bacterial infections, in particular those caused by anaerobic species; and it can also be used for the treatment of important protozoal diseases, e.g. malaria, most effectively in combination with primaquine. Resistance to lincomycin and clindamycin may be caused by methylation of 23S ribosomal RNA, modification of the antibiotics by specific enzymes or active efflux from the periplasmic space.
Url:
DOI: 10.1007/s00253-003-1545-7
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001785
- to stream Istex, to step Curation: 001785
- to stream Istex, to step Checkpoint: 000E22
- to stream Main, to step Merge: 001F96
- to stream Main, to step Curation: 001F81
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lincomycin, clindamycin and their applications</title><author><name sortKey="Spizek, J" sort="Spizek, J" uniqKey="Spizek J" first="J." last="Spížek">J. Spížek</name></author><author><name sortKey=" Ezanka, T" sort=" Ezanka, T" uniqKey=" Ezanka T" first="T." last=" Ezanka">T. Ezanka</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:418CD4723E5428405FAB20C8305B8410C07F1A8F</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1007/s00253-003-1545-7</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-HM2J8PLN-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001785</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001785</idno><idno type="wicri:Area/Istex/Curation">001785</idno><idno type="wicri:Area/Istex/Checkpoint">000E22</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E22</idno><idno type="wicri:doubleKey">0175-7598:2004:Spizek J:lincomycin:clindamycin:and</idno><idno type="wicri:Area/Main/Merge">001F96</idno><idno type="wicri:Area/Main/Curation">001F81</idno><idno type="wicri:Area/Main/Exploration">001F81</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Lincomycin, clindamycin and their applications</title><author><name sortKey="Spizek, J" sort="Spizek, J" uniqKey="Spizek J" first="J." last="Spížek">J. Spížek</name><affiliation wicri:level="3"><country xml:lang="fr">République tchèque</country><wicri:regionArea>Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Prague</wicri:regionArea><placeName><settlement type="city">Prague</settlement><region type="région" nuts="2">Bohême centrale</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">République tchèque</country></affiliation></author><author><name sortKey=" Ezanka, T" sort=" Ezanka, T" uniqKey=" Ezanka T" first="T." last=" Ezanka">T. Ezanka</name><affiliation wicri:level="3"><country xml:lang="fr">République tchèque</country><wicri:regionArea>Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Prague</wicri:regionArea><placeName><settlement type="city">Prague</settlement><region type="région" nuts="2">Bohême centrale</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Applied Microbiology and Biotechnology</title><title level="j" type="abbrev">Appl Microbiol Biotechnol</title><idno type="ISSN">0175-7598</idno><idno type="eISSN">1432-0614</idno><imprint><publisher>Springer-Verlag; http://www.springer.de</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2004-05-01">2004-05-01</date><biblScope unit="volume">64</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="455">455</biblScope><biblScope unit="page" to="464">464</biblScope></imprint><idno type="ISSN">0175-7598</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0175-7598</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Lincomycin and clindamycin are lincosamide antibiotics used in clinical practice. Both antibiotics are bacteriostatic and inhibit protein synthesis in sensitive bacteria. They may even be bactericidal at the higher concentrations that can be reached in vivo . Clindamycin is usually more active than lincomycin in the treatment of bacterial infections, in particular those caused by anaerobic species; and it can also be used for the treatment of important protozoal diseases, e.g. malaria, most effectively in combination with primaquine. Resistance to lincomycin and clindamycin may be caused by methylation of 23S ribosomal RNA, modification of the antibiotics by specific enzymes or active efflux from the periplasmic space.</div></front></TEI><affiliations><list><country><li>République tchèque</li></country><region><li>Bohême centrale</li></region><settlement><li>Prague</li></settlement></list><tree><country name="République tchèque"><region name="Bohême centrale"><name sortKey="Spizek, J" sort="Spizek, J" uniqKey="Spizek J" first="J." last="Spížek">J. Spížek</name></region><name sortKey=" Ezanka, T" sort=" Ezanka, T" uniqKey=" Ezanka T" first="T." last=" Ezanka">T. Ezanka</name><name sortKey="Spizek, J" sort="Spizek, J" uniqKey="Spizek J" first="J." last="Spížek">J. Spížek</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F81 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F81 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:418CD4723E5428405FAB20C8305B8410C07F1A8F
|texte= Lincomycin, clindamycin and their applications
}}
| This area was generated with Dilib version V0.6.33. |  |